Text to Speech (TTS) is Having a Moment Text to speech (TTS) is getting really good. The latest models read text naturally and can clone voices with under a minute of reference audio. What's even more exciting are new models and frameworks that allow you to do this
Below are simple instructions to install the official Atlassian Model Context Protocol (MCP) server to access Bitbucket, JIRA, and Confluence servers from Claude Code. Instructions to install official Atlassian MCP to Claude Code 1) Install Claude Code following Anthropic's instructions: npm install -g @anthropic-ai/claude-code 2) Create a
Naming a company can be frustrating, especially as common domain names keep dwindling. A friend shared a helpful process that he's used for consumer brands in the past. I've found it's also helpful for any nascent company or brand: Brand Naming Exercise Part 1:
I keep being impressed by the new ways I see people using AI and how these ideas have yet to go mainstream. Prototyping with AI at HBS November 2024, Professor Jeff Bussgang, Professor Christina Wallace, and I taught a hands-on workshop in the Launching Technology Ventures (LTV) class at Harvard
I hope this saves you some time too if you found this searching for a simple solution! Context Every time I find myself trying to re-learn something I'm taking the time to document. This is one simple example: I'm a fan of Cloudflare domains because they
I’m still pondering on whether there’s a venture-backable opportunity in the data center sitting in my basement, but the last time I felt this curious about a technical shift (besides LLMs) was when we blew the circuits in Paul Benigeri’s Stanford dorm mining altcoins in 2013. The
Automating everyday manual tasks has been one of the highest-leverage productivity hacks I've found for LLMs. Nowhere have I seen more manual tasks than in spreadsheets (I even cofounded a company to help save biotech accountants from some of this manual work). One of my favorite applications is
Cassava Sciences is a clinical-stage biotechnology company developing several late-stage treatments for Alzheimer's. A friend recently heard about Cassava in the news and asked me if I had any insights based on the recent biotech data I've been exploring. I thought it was a good opportunity
Bill Trench had a great question in his recent application for a new investor role at First Round Capital: Would you invest in OpenAI at a $150B valuation today? Why or why not? There are a lot of opinions going on about OpenAI, but I've struggled to find
Some current working drafts are below. If any of these pique your interest, Shoot me a note! You can learn more about this site here, and you can subscribe in the meantime if you'd like to stay up to date and receive emails when new notes are published.